The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell offMarket Watch • 04/23/26
Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation24/7 Wall Street • 04/23/26
Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis ReschedulingGlobeNewsWire • 04/23/26
BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and SummerGlobeNewsWire • 04/23/26
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substanceMarket Watch • 04/22/26
Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: ReportBenzinga • 04/22/26
1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It?The Motley Fool • 04/22/26
Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical CareGlobeNewsWire • 04/20/26
The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana MarketThe Motley Fool • 04/20/26
Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise YouThe Motley Fool • 04/13/26
Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced ConsumerGlobeNewsWire • 04/08/26
Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey EnthusiastsGlobeNewsWire • 04/07/26
Why Tilray Brands Investors Shouldn't Expect the Company to Post a Profit Anytime SoonThe Motley Fool • 04/06/26